Benedetta Mazzanti

Benedetta Mazzanti

Auto-generated profile, based on publicly available information

Benedetta Mazzanti

Department of Experimental and Clinical Medicine, University of Florence, Largo Brambilla 3, 50134, Florence, Italy.

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2016 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
BMBenedetta Mazzanti
Benedetta Mazzanti
BLBruno Lorenzi
Bruno Lorenzi
ABAnnalisa Borghini
Annalisa Borghini
MBMargherita Boieri
Margherita Boieri
LBLara Ballerini
Lara Ballerini
FPFederica Pessina
Federica Pessina
Background: Anal incontinence is a disabling condition that adversely affects the quality of life of a large number of patients, mainly with anal sphincter lesions. In a previous experimental work, in-vitro expanded bone marrow (BM)-derived mesenchymal stem cells (MSC) were demonstrated to enhance sphincter healing after injury and primary repair in a rat preclinical model. In the present article we investigated whether unexpanded BM mononuclear cells (MNC) may also be effective. Methods: Thirty-two rats, divided into groups, underwent sphincterotomy and repair (SR) with primary suture of anal sphincters plus intrasphincteric injection of saline (CTR), or of in-vitro expanded MSC, or of minimally manipulated MNC; moreover, the fourth group underwent sham operation. At day 30, histologic, morphometric, in-vitro contractility, and functional analysis were performed. Results: Treatment with both MSC and MNC improved muscle regeneration and increased contractile function of anal sphincters after SR compared with CTR (p < 0.05). No significant difference was observed between the two BM stem cell types used. GFP-positive cells (MSC and MNC) remained in the proximity of the lesion site up to 30 days post injection. Conclusions: In the present study we demonstrated in a preclinical model that minimally manipulated BM-MNC were as effective as in-vitro expanded MSC for the recovery of anal sphincter injury followed by primary sphincter repair. These results may serve as a basis for improving clinical applications of stem cell therapy in human anal incontinence treatment.

17 July 2013 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
PDF file
BMB. Mazzanti
B. Mazzanti
BLB. Lorenzi
B. Lorenzi
PLP. Lorenzoni
P. Lorenzoni
ABA. Borghini
A. Borghini
MBM. Boieri
M. Boieri
FPFederica Pessina
Federica Pessina

31 July 2013 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
VCValentina Carrai
Valentina Carrai
IDIrene Donnini
Irene Donnini
BMBenedetta Mazzanti
Benedetta Mazzanti
RARenato Alterini
Renato Alterini
MAMaria Pia Amato
Maria Pia Amato
RSRiccardo Saccardi
Riccardo Saccardi

17 April 2014 in Endocrine Abstracts
Verified
Journal Article
Closed access
FDFranco Alessandra Di
Franco Alessandra Di
DGDaniele Guasti
Daniele Guasti
BMBenedetta Mazzanti
Benedetta Mazzanti
TETonino Ercolino
Tonino Ercolino
Gabriella NesiGabriella Nesi
Gabriella Nesi
Michaela LuconiMichaela Luconi
Michaela Luconi
The recent discovery of the presence of brown adipose tissue (BAT) also in human adults is pivotal for development of anti-obesity therapies. This type of fat, in fact, mainly consists of brite cells (brown adipocytes appearing for a browning process in white fat) which are involved in adiposity control. The origin of brite cells in adult white adipose tissue (WAT) is still unclear as human cell models are lacking. Our study demonstrated the presence of BAT islets dispersed in periadrenal WAT of adult patients affected by pheochromocytoma tumors, secreting catecholamines. All the enrolled patients affected by pheochromocytoma (n=8, mean±S.D.: 48±19 years for age, 23.8±2.0 kg/m2 for body mass index, BMI), but not the one with adenocortical adenoma, presented extensive BAT islets in the fat surrounding the tumor lesion (uncoupling-protein-1 UCP-1 mean 2–ΔΔCt±S.D. of the expression vs GAPDH:150134±106137) and had elevated levels of urinary total metanephrines (normetanephrines+metanephrines mean±S.D.: 4447±1927 μg/24 h) which negatively correlated with BMI (r=0.854, r2=0.730, P=0.007, n=8). From this fat depot, expressing brite and classical markers in addition to high levels of UCP-1, for the first time, we isolated and characterized brown adipose stem cells (B-ASC) and compared their properties with precursors obtained from subcutaneous WAT (S-ASC) of the same patients. B-ASC showed mesenchymal, stem and multipotency features as well as expression of brite/classical markers. When differentiated toward white adipose phenotype, they accumulated more lipid droplets and smaller than the differentiated adipocytes deriving from S-ASC. Using specific brown differentiation cocktails, we could not obtain mature brown adipocytes but brown commitment only in B- and not in S-ASC. In conclusion, we demonstrated the presence of BAT precursors, different from WAT, in fat surrounding pheochromocytoma lesions, representing a unique in vitro human stem cell model of brown adipose tissue to study brown adipogenesis and browning process. This study was supported by funds from PRIN2010-11 (prot. 2010C8ERKX, Italian Ministry of University and Research) and from Fondazione Ente Cassa di Risparmio di Pistoia and Pescia.

13 May 2016 in Endocrine Abstracts
Verified
Journal Article
Closed access
AFAlessandra Di Franco
Alessandra Di Franco
DGDaniele Guasti
Daniele Guasti
RSROBERTA SQUECCO
ROBERTA SQUECCO
BMBenedetta Mazzanti
Benedetta Mazzanti
FRFrancesca Rossi
Francesca Rossi
Michaela LuconiMichaela Luconi
Michaela Luconi
The potential therapeutic applications of targeting brown adipose tissue open new clinical avenues in fighting against metabolic pathologies. However, due to the limited brown depots in adult humans, dramatically reduced after birth, solid cell models to study human brown adipogenesis and its pathophysiological regulation are urgently needed. In our study, we characterized a novel human model of brown adipose stem cells, hfB-ASC, derived from fetal interscapular brown fat depots. After demonstration of the mesenchymal and stem nature of the isolated cells, we studied their differentiation potential, in particular, towards the brown lineage. Following in-vitro induced adipogenesis, these cells exhibit several features of brown fat cells, such as the elevated expression of mature and early brown markers, UCP-1 and PRDM16, respectively (2−ΔΔCt: 2295±864 and 19.3±8.0 for UCP-1 and PRDM16), but not of white markers as leptin, compared to in-vitro differentiated white adipose stem cells. They maintain also a specific intrinsic differentiation program to functional brown adipocytes, and even spontaneously organize in organoid structures with brown features. Moreover, for the first time, we investigated the thermogenic and electrophysiological activity of the in-vitro-derived fetal brown adipocytes compared to their undifferentiated hfB-ASC precursors, in basal conditions and after acute administration of norepinephrine. Compared to adipocytes obtained from in-vitro differentiation of white adipose stem cells, brown adipocytes from hfB-ASC show a significantly increase in temperature vs. undifferentiated cells (Δtemperature: 0.30 °C±0.10, P=0.02), as well as following acute administration of 10 μM norepinephrine (Δtemperature: 0.21 °C±0.20, P=0.02). In conclusion, starting from interscapular brown fat of human fetus, we developed and functionally characterized a novel physiological brown adipose stem cell model. This model may represent a unique opportunity for further studies on brown adipogenesis processes in humans, as well as the most suitable target to develop novel therapeutic approaches in order to stimulate brown activity in metabolic pathologies.